Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Basun

Showing results (11-20 of 55) with videos related to

Pageof 6
Sort By:
Journal of Alzheimer'S Disease : JAD|September 25, 2015
Lithium as a Treatment for Alzheimer's Disease: A Systematic Review and Meta-AnalysisShinji Matsunaga, Taro Kishi, Peter Annas, et al.
Alzheimer'S Research & Therapy|June 7, 2016
High tau levels in cerebrospinal fluid predict nursing home placement and rapid progression in Alzheimer's diseaseMalin Degerman Gunnarsson, Martin Ingelsson, Kaj Blennow, et al.
Current Alzheimer Research|August 31, 2011
Influence of lithium treatment on GDNF serum and CSF concentrations in patients with early Alzheimer's diseaseGuido Straten, Ralf Saur, Christoph Laske, et al.
Lakartidningen|March 11, 2020
[Alzheimer's disease - the most common cause of dementia]Nenad Bogdanovic, Oskar Hansson, Henrik Zetterberg, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|October 14, 2003
Determination of isoprostanes in urine samples from Alzheimer patients using porous graphitic carbon liquid chromatography-tandem mass spectrometryKristina Claeson Bohnstedt, Bo Karlberg, Lars-Olof Wahlund, et al.
Acta Neurologica Scandinavica. Supplementum|February 27, 2003
Clinical findings in nondemented mutation carriers predisposed to Alzheimer's disease: a model of mild cognitive impairmentOve Almkvist, Karin Axelman, Hans Basun, et al.
Journal of Alzheimer'S Disease : JAD|March 12, 2009
Increase of BDNF serum concentration in lithium treated patients with early Alzheimer's diseaseThomas Leyhe, Gerhard W Eschweiler, Elke Stransky, et al.
Journal of Neurology|May 22, 2002
Treatment of acute ischaemic stroke with the low-affinity, use-dependent NMDA antagonist AR-R15896AR. A safety and tolerability studyHans-Christoph Diener, Abdullatif AlKhedr, Otto Busse, et al.
Neuroscience Letters|May 8, 2007
Longitudinal stability of CSF biomarkers in Alzheimer's diseaseKaj Blennow, Henrik Zetterberg, Lennart Minthon, et al.
Alzheimer'S Research & Therapy|April 7, 2016
Safety and tolerability of BAN2401--a clinical study in Alzheimer's disease with a protofibril selective Aβ antibodyVeronika Logovinsky, Andrew Satlin, Robert Lai, et al.
Pageof 6

Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
Journal of Alzheimer'S Disease : JAD|September 25, 2015
Lithium as a Treatment for Alzheimer's Disease: A Systematic Review and Meta-AnalysisShinji Matsunaga, Taro Kishi, Peter Annas, et al.
Alzheimer'S Research & Therapy|June 7, 2016
High tau levels in cerebrospinal fluid predict nursing home placement and rapid progression in Alzheimer's diseaseMalin Degerman Gunnarsson, Martin Ingelsson, Kaj Blennow, et al.
Current Alzheimer Research|August 31, 2011
Influence of lithium treatment on GDNF serum and CSF concentrations in patients with early Alzheimer's diseaseGuido Straten, Ralf Saur, Christoph Laske, et al.
Lakartidningen|March 11, 2020
[Alzheimer's disease - the most common cause of dementia]Nenad Bogdanovic, Oskar Hansson, Henrik Zetterberg, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|October 14, 2003
Determination of isoprostanes in urine samples from Alzheimer patients using porous graphitic carbon liquid chromatography-tandem mass spectrometryKristina Claeson Bohnstedt, Bo Karlberg, Lars-Olof Wahlund, et al.
Acta Neurologica Scandinavica. Supplementum|February 27, 2003
Clinical findings in nondemented mutation carriers predisposed to Alzheimer's disease: a model of mild cognitive impairmentOve Almkvist, Karin Axelman, Hans Basun, et al.
Journal of Alzheimer'S Disease : JAD|March 12, 2009
Increase of BDNF serum concentration in lithium treated patients with early Alzheimer's diseaseThomas Leyhe, Gerhard W Eschweiler, Elke Stransky, et al.
Journal of Neurology|May 22, 2002
Treatment of acute ischaemic stroke with the low-affinity, use-dependent NMDA antagonist AR-R15896AR. A safety and tolerability studyHans-Christoph Diener, Abdullatif AlKhedr, Otto Busse, et al.
Neuroscience Letters|May 8, 2007
Longitudinal stability of CSF biomarkers in Alzheimer's diseaseKaj Blennow, Henrik Zetterberg, Lennart Minthon, et al.
Alzheimer'S Research & Therapy|April 7, 2016
Safety and tolerability of BAN2401--a clinical study in Alzheimer's disease with a protofibril selective Aβ antibodyVeronika Logovinsky, Andrew Satlin, Robert Lai, et al.
Pageof 6